AstraZeneca (AZN)
Health Care Sector

  • Latest quote

    7,316.00p (mid)

  • Current Change (%)

    0.97%

  • Price

    Bid: 7,316.00p

    Offer: 7,318.00p

  • Today

    High: 7,338.00p

    Low: 7,277.00p

  • This year

    High: 7,580.00p

    Low: 5,325.00p

  • Information

    Volume: 270,817

    Market Cap: £95938.98M

NOTE: This is based on 319 open tips for this company


Total Number of Share tips :

614

View all AstraZeneca Tips




AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
Lynparza approved in China for 1L BRCAm ovarian 07:00 - December 5, 2019
AstraZeneca divests Seroquel rights: US and Canada 07:00 - December 3, 2019
Total Voting Rights 15:00 - December 2, 2019
Block listing Interim Review 15:00 - December 2, 2019
Imfinzi granted FDA Priority Review for SCLC 07:00 - November 29, 2019
Calquence approved in CLL in the US 18:15 - November 21, 2019
Qtrilmet approved in the EU for treatment of T2D 07:00 - November 15, 2019
FDA accepts regulatory submission for selumetinib 07:00 - November 14, 2019
Anifrolumab demonstrated superiority in TULIP 2 07:00 - November 12, 2019
Roxadustat pooled analyses: no increased CV risk 07:00 - November 11, 2019
Roxadustat significantly increased haemoglobin 07:00 - November 8, 2019
Calquence data to show improved progression-free 14:10 - November 6, 2019
Total Voting Rights 15:00 - November 1, 2019
AstraZeneca divests rights to Seroquel and 07:00 - October 30, 2019
Imfinzi and Imfinzi plus tremelimumab delayed 15:31 - October 28, 2019

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today